ADLM Diagnostics Innovation and COVID Testing

Two men, Nick A. (left) and Nigel (right), sit at a white table, engaging in a lively and friendly conversation. Both wear checkered shirts and lavalier microphones, suggesting a filmed discussion or interview. Nick holds tissue samples in one hand and gestures animatedly, while Nigel smiles in response. Each has a white mug labeled with their name and a purple star logo. The background is a bright white, creating a clean and professional studio setting.
Resources

ADLM Diagnostics Innovation and COVID Testing

Sector: Diagnostics
Topic: Bio Break
YouTube video thumbnail

In this Bio Break episode, Nick Allan and Nigel Syrotuck reflect on recent ADLM diagnostics innovation and how it has shaped the future of clinical testing. The Association for Diagnostics & Laboratory Medicine (ADLM) recently wrapped its annual showcase in Chicago, and as always, it left a strong impression on the medtech community.

While discussing highlights from the show, Nick and Nigel zero in on a perfect case study of ADLM diagnostics innovation: the evolution of COVID-19 testing. From the early days of enzyme-linked immunosorbent assays (ELISAs) to the familiar lateral flow tests we now perform at home, diagnostics have become faster, simpler, and more accessible. This transformation—from complex lab environments to point-of-care and even bathroom-counter diagnostics—was on full display at ADLM.

From the Lab to the Bathroom Counter

As Nick points out, one of the most remarkable shifts in diagnostics is how complicated procedures have been distilled into everyday routines. What once required trained technicians in controlled environments can now be done at home, often with little more than a test strip and a timer. The lateral flow transformation is a clear example of how ADLM’s influence and technology leadership help shape the direction of consumer-friendly diagnostics.

Learn more about StarFish Medical.

Black alarm clock disintegrating into particles beside the bold text ‘Faster launch?’ on a yellow background, symbolizing accelerating medical device development timelines.

Reducing Device Development Timelines: People, Process, and Tools

Ariana Wilson and Mark Drlik explore how teams can reduce the device development timeline without compromising quality or compliance.

Gloved hand holds fluorescent liquid over a UV-lit surface with green glow and red arrow pointing to the light, captioned ‘See the Clean?

Fluorescent Soil Load Test

Nick Allan and Nigel Syrotuck explore a creative approach to visualizing cleaning validation using a fluorescent soil load.

Gloved hands insert a swab into a sealed vial beside a crossed-out O₂ symbol with the text “No Oxygen Allowed?” illustrating anaerobic sample collection.

Anaerobic Sample Collection Explained

Nick Allan joins Nigel Syrotuck to explore how anaerobic sample collection works and why it’s vital for studying bacteria that cannot survive in oxygen.

icons representing different medical device classes

Difference Between Class 1, 2, and 3 Medical Devices

Understanding medical device classifications is critical for compliance, risk management, and time-to-market success. Whether you’re designing a wearable sensor or a life-sustaining implant, knowing how your device fits into FDA Class 1, 2, or 3 categories is essential.